There has been considerable concern surrounding AEW TNT Champion Adam Copeland and his opponent Malakai Black following their intense Barbed Wire Steel Cage Match at at the 2024 AEW Double or Nothing pay-per-view.

Unfortunately, Copeland has announced that he has sustained fractured tibia during the match and will require surgery. This news has elicited a wave of universal sadness and sympathy among the AEW community, as reported by PWInsider.com.

Copeland’s presence backstage has been described as invaluable, with many talents viewing him as a great mentor and sounding board. His absence, albeit temporary, is anticipated to leave a significant void behind the scenes. Despite the setback, Copeland’s contributions and influence within AEW remain deeply appreciated by his peers.

In a poignant nod to his wrestling legacy, Copeland incorporated “The Brood” name into his entrance at Double or Nothing. It’s worth noting that Copeland, along with Gangrel and Christian Cage, were integral members of The Brood faction in WWE during the late 1990s. Interestingly, Copeland retains the trademark rights to the group’s name.

Advertising
Advertising

As Copeland embarks on his road to recovery, the AEW community stands united in offering support and well-wishes for his speedy return. His resilience and leadership continue to inspire and resonate with fans and colleagues alike, underscoring his enduring impact on the wrestling world.

What are your thoughts on Adam Copeland’s injury and the impact it will have on AEW, both in terms of his presence backstage and in the ring? How do you feel about his use of “The Brood” name during his entrance at Double or Nothing? Share your reactions and well-wishes for Copeland’s recovery in the comment section below!

Steve Carrier

Steve is the Founder of RingsideNews. He has been writing about professional wrestling since 1996. He first got into website development at the time and has been focusing on bringing his readers the best professional wrestling news at it's highest quality.

Disqus Comments Loading...